What is the primary goal of risk assessment in sterile compounding?

The primary goal of risk assessment in sterile compounding is to identify potential hazards and minimize the risk of contamination. In sterile compounding, the primary concern is to maintain the integrity and safety of the compounded medications. Contamination can lead to patient harm, including infection and adverse reactions.

Through risk assessment, compounding facilities systematically evaluate different processes, equipment, and environments to pinpoint areas where contamination is likely to occur. This proactive approach allows for the implementation of strategies and best practices aimed at reducing these risks, such as improving cleanliness protocols, enhancing training, and ensuring proper technique during the compounding process.

Other aspects, such as staff education on errors, financial risks, or medication labeling, play important roles in the overall operation of a compounding pharmacy but do not directly address the critical focus of risk assessment in maintaining sterile conditions.